158 related articles for article (PubMed ID: 26896598)
1. ELISA index of serum fucosylated haptoglobin for diagnosis of HCC using the normal and reverse AAL ELISA.
Shang S; Qin X; Li W; Zhang S; Liu Y
Discov Med; 2016 Jan; 21(113):15-23. PubMed ID: 26896598
[TBL] [Abstract][Full Text] [Related]
2. Rapid diagnosis of hepatocellular carcinoma using a haptoglobin ELISA assay based on AAL-coated magnetic beads.
Shang S; Sun L; Li W; Qin X; Zhang S; Liu Y
Discov Med; 2016 Sep; 22(120):97-104. PubMed ID: 27755965
[TBL] [Abstract][Full Text] [Related]
3. Serum fucosylated paraoxonase 1 as a potential glycobiomarker for clinical diagnosis of early hepatocellular carcinoma using ELISA Index.
Zhang S; Jiang K; Zhang Q; Guo K; Liu Y
Glycoconj J; 2015 May; 32(3-4):119-25. PubMed ID: 25702281
[TBL] [Abstract][Full Text] [Related]
4. Analysis of serum Haptoglobin using glycoproteomics and lectin immunoassay in liver diseases in Hepatitis B virus infection.
Dalal K; Dalal B; Bhatia S; Shukla A; Shankarkumar A
Clin Chim Acta; 2019 Aug; 495():309-317. PubMed ID: 31014754
[TBL] [Abstract][Full Text] [Related]
5. Multiple lectin assays for detecting glyco-alteration of serum GP73 in liver diseases.
Jiang K; Shang S; Li W; Guo K; Qin X; Zhang S; Liu Y
Glycoconj J; 2015 Dec; 32(9):657-64. PubMed ID: 26342810
[TBL] [Abstract][Full Text] [Related]
6. Serum fucosylated haptoglobin in chronic liver diseases as a potential biomarker of hepatocellular carcinoma development.
Asazawa H; Kamada Y; Takeda Y; Takamatsu S; Shinzaki S; Kim Y; Nezu R; Kuzushita N; Mita E; Kato M; Miyoshi E
Clin Chem Lab Med; 2015 Jan; 53(1):95-102. PubMed ID: 25060348
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of AFP-negative early-stage hepatocellular carcinoma using Fuc-PON1.
Shu H; Li W; Shang S; Qin X; Zhang S; Liu Y
Discov Med; 2017 Mar; 23(126):163-168. PubMed ID: 28472609
[TBL] [Abstract][Full Text] [Related]
8. Reverse lectin ELISA for detecting fucosylated forms of α1-acid glycoprotein associated with hepatocellular carcinoma.
Åström E; Stål P; Zenlander R; Edenvik P; Alexandersson C; Haglund M; Rydén I; Påhlsson P
PLoS One; 2017; 12(3):e0173897. PubMed ID: 28296934
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a novel lectin-antibody ELISA system to determine core-fucosylated haptoglobin.
Shimomura M; Nakayama K; Azuma K; Terao N; Nishino K; Takamatsu S; Nakano M; Takahashi S; Kobayashi Y; Murata K; Kamada Y; Miyoshi E
Clin Chim Acta; 2015 Jun; 446():30-6. PubMed ID: 25861849
[TBL] [Abstract][Full Text] [Related]
10. Clinical application of a lectin-antibody ELISA to measure fucosylated haptoglobin in sera of patients with pancreatic cancer.
Matsumoto H; Shinzaki S; Narisada M; Kawamoto S; Kuwamoto K; Moriwaki K; Kanke F; Satomura S; Kumada T; Miyoshi E
Clin Chem Lab Med; 2010 Apr; 48(4):505-12. PubMed ID: 20128732
[TBL] [Abstract][Full Text] [Related]
11. Study of serum haptoglobin and its glycoforms in the diagnosis of hepatocellular carcinoma: a glycoproteomic approach.
Ang IL; Poon TC; Lai PB; Chan AT; Ngai SM; Hui AY; Johnson PJ; Sung JJ
J Proteome Res; 2006 Oct; 5(10):2691-700. PubMed ID: 17022640
[TBL] [Abstract][Full Text] [Related]
12. Aided Diagnosis of Hepatocellular Carcinoma Using Serum Fucosylated Haptoglobin Ratios.
Shang S; Li W; Qin X; Zhang S; Liu Y
J Cancer; 2017; 8(5):887-893. PubMed ID: 28382152
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of fucosylated GP73 in the differential diagnosis of hepatocellular carcinoma.
Zhao Y; Zhang L; Huo L; Pei L; Li Q; Li H; Jin L
Int J Biol Markers; 2018 Nov; 33(4):439-446. PubMed ID: 30238841
[TBL] [Abstract][Full Text] [Related]
14. Serum paraoxonase 1 heteroplasmon, a fucosylated, and sialylated glycoprotein in distinguishing early hepatocellular carcinoma from liver cirrhosis patients.
Sun C; Chen P; Chen Q; Sun L; Kang X; Qin X; Liu Y
Acta Biochim Biophys Sin (Shanghai); 2012 Sep; 44(9):765-73. PubMed ID: 22751611
[TBL] [Abstract][Full Text] [Related]
15. Reevaluation of Pholiota squarrosa lectin-reactive haptoglobin as a pancreatic cancer biomarker using an improved ELISA system.
Kusama K; Okamoto Y; Saito K; Kasahara T; Murata T; Ueno Y; Kobayashi Y; Kamada Y; Miyoshi E
Glycoconj J; 2017 Aug; 34(4):537-544. PubMed ID: 28455724
[TBL] [Abstract][Full Text] [Related]
16. Reevaluation of a lectin antibody ELISA kit for measuring fucosylated haptoglobin in various conditions.
Kamada Y; Kinoshita N; Tsuchiya Y; Kobayashi K; Fujii H; Terao N; Kamihagi K; Koyama N; Yamada S; Daigo Y; Nakamura Y; Taniguchi N; Miyoshi E
Clin Chim Acta; 2013 Feb; 417():48-53. PubMed ID: 23262369
[TBL] [Abstract][Full Text] [Related]
17. The diagnostic value of serum fucosylated fetuin A in hepatitis B virus-related liver diseases.
Li L; Gu X; Fang M; Ji J; Yi C; Gao C
Clin Chem Lab Med; 2016 Apr; 54(4):693-701. PubMed ID: 26035113
[TBL] [Abstract][Full Text] [Related]
18. A comparative evaluation of Golgi protein-73, fucosylated hemopexin, α-fetoprotein, and PIVKA-II in the serum of patients with chronic hepatitis, cirrhosis, and hepatocellular carcinoma.
Morota K; Nakagawa M; Sekiya R; Hemken PM; Sokoll LJ; Elliott D; Chan DW; Dowell BL
Clin Chem Lab Med; 2011 Apr; 49(4):711-8. PubMed ID: 21231906
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Fucosylated Haptoglobin and Mac-2 Binding Protein as Serum Biomarkers to Estimate Liver Fibrosis in Patients with Chronic Hepatitis C.
Tawara S; Tatsumi T; Iio S; Kobayashi I; Shigekawa M; Hikita H; Sakamori R; Hiramatsu N; Miyoshi E; Takehara T
PLoS One; 2016; 11(3):e0151828. PubMed ID: 27002630
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of aberrant protein glycosylation in liver cancer plasma by AAL-enrichment and MRM mass spectrometry.
Ahn YH; Shin PM; Kim YS; Oh NR; Ji ES; Kim KH; Lee YJ; Kim SH; Yoo JS
Analyst; 2013 Nov; 138(21):6454-62. PubMed ID: 24027776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
